Pharmosa Biopharm Inc. (6875.TWO)
TWD 51.5
(2.18%)
TWD 51.5
(2.18%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -2.82 Million TWD | 104.26% |
| 2022 | -265.85 Million TWD | -4.15% |
| 2021 | -255.26 Million TWD | -43.54% |
| 2020 | -177.83 Million TWD | -27.81% |
| 2019 | -139.14 Million TWD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -58.03 Million TWD | -35.85% |
| 2024 Q1 | -52.28 Million TWD | 42.0% |
| 2023 Q3 | 231.7 Million TWD | 446.75% |
| 2023 FY | 11.31 Million TWD | 104.26% |
| 2023 Q4 | -90.13 Million TWD | -138.9% |
| 2023 Q2 | -66.82 Million TWD | -5.33% |
| 2023 Q1 | -63.43 Million TWD | -35.48% |
| 2022 Q4 | -46.82 Million TWD | 27.96% |
| 2022 Q3 | -65 Million TWD | 0.0% |
| 2022 FY | -265.85 Million TWD | -4.15% |
| 2021 FY | -255.26 Million TWD | -43.54% |
| 2020 FY | -177.83 Million TWD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Great Novel Therapeutics Biotech & Medicals | -65.81 Million TWD | 95.71% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -93.95 Million TWD | 96.994% |
| Visgeneer Inc. | -21.15 Million TWD | 86.653% |
| Genomics BioSci & Tech. Co.,Ltd. | -84.99 Million TWD | 96.677% |
| Advagene Biopharma Co., Ltd. | -93.33 Million TWD | 96.974% |
| Sagittarius Life Science Corp | -64.37 Million TWD | 95.613% |
| NaviFUS Corp. | -76.42 Million TWD | 96.305% |
| BioGend Therapeutics Co., Ltd. | -176.54 Million TWD | 98.4% |
| Shine-On BioMedical Co.,Ltd. | -62.68 Million TWD | 95.495% |
| TaiRx, Inc. | -214.69 Million TWD | 98.685% |
| Andros Pharmaceuticals Co.,Ltd | -67.69 Million TWD | 95.828% |
| Lin BioScience, Inc. | -1.09 Billion TWD | 99.743% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.61 Million TWD | 57.277% |
| Lumosa Therapeutics Co., Ltd. | -375.62 Million TWD | 99.248% |
| Anti-Microbial Savior BioteQ Co., Ltd | -56.74 Million TWD | 95.024% |
| BioLASCO Taiwan Co., Ltd. | 63.33 Million TWD | 104.459% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 281.85 Million TWD | 101.002% |
| Sunmax Biotechnology Co., Ltd. | 894.79 Million TWD | 100.316% |
| RBC Bioscience Corporation | 14.53 Million TWD | 119.424% |
| Bio Preventive Medicine Corp. | -70.58 Million TWD | 95.999% |
| Syngen Biotech Co.,Ltd. | 334.08 Million TWD | 100.845% |
| G&E Herbal Biotechnology Co., Ltd. | 80.68 Million TWD | 103.5% |
| AP Biosciences Inc | -347.47 Million TWD | 99.187% |
| EirGenix Inc. | -1.03 Billion TWD | 99.726% |
| Enimmune corporation | -243.47 Million TWD | 98.84% |
| Lukas Biomedical Inc. | -43.56 Million TWD | 93.517% |
| GlycoNex Incorporation | -259.86 Million TWD | 98.913% |
| BRIM Biotechnology, Inc. | -694.12 Million TWD | 99.593% |
| Level Biotechnology Inc. | 67.55 Million TWD | 104.18% |
| TaiMed Biologics Inc. | -166.23 Million TWD | 98.301% |
| Mycenax Biotech Inc. | -602.1 Million TWD | 99.531% |
| SynCore Biotechnology Co.,Ltd | -45.5 Million TWD | 93.794% |
| Eusol Biotech Co.,Ltd. | -41.48 Million TWD | 93.192% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -2.25 Million TWD | -25.344% |
| Feng Chi Biotech Corp. | 24.16 Million TWD | 111.688% |
| NeoCore Technology Co., Ltd. | -84.94 Million TWD | 96.675% |
| TWi Biotechnology, Inc. | -169.55 Million TWD | 98.334% |
| Neith Corporation | -48.85 Million TWD | 94.22% |
| Sunny Pharmtech Inc. | -72.09 Million TWD | 96.083% |
| VBI | -16.13 Million TWD | 82.494% |
| BiOptic Inc. | 44.05 Million TWD | 106.41% |
| Ever Supreme Bio Technology Co., Ltd | 337.73 Million TWD | 100.836% |
| Sinew Pharma Inc. | -186.25 Million TWD | 98.484% |
| Greenyn Biotechnology Co., Ltd | 159.81 Million TWD | 101.767% |
| GeneReach Biotechnology Corp. | -229.28 Million TWD | 98.768% |
| CHO Pharma, Inc. | -268.99 Million TWD | 98.95% |
| Medigen Biotechnology Corp. | -1.23 Billion TWD | 99.771% |
| 3D Global Biotech Inc. | -62.85 Million TWD | 95.507% |
| Senhwa Biosciences, Inc. | -311.11 Million TWD | 99.092% |
| Intech Biopharm Corporation | -304.39 Million TWD | 99.072% |
| Oneness Biotech Co., Ltd. | -1.09 Billion TWD | 99.742% |
| TCI GENE Inc. | 10.04 Million TWD | 128.102% |
| MegaPro Biomedical Co., Ltd | -127.25 Million TWD | 97.781% |
| Taiwan Bio Therapeutics Co., Ltd | -212.2 Million TWD | 98.669% |
| NatureWise Biotech & Medicals Corporation | 3.43 Million TWD | 182.236% |
| PharmaEngine, Inc. | 277.18 Million TWD | 101.019% |
| Savior Lifetec Corporation | -2.42 Million TWD | -16.694% |
| TaiGen Biopharmaceuticals Holdings Limited | -174.69 Million TWD | 98.384% |
| OBI Pharma, Inc. | -2.08 Billion TWD | 99.865% |
| Meribank Biotech Co., Ltd | -123.15 Million TWD | 97.707% |
| Medigen Vaccine Biologics Corporation | -1.21 Billion TWD | 99.767% |
| Acepodia, Inc. | -435.97 Million TWD | 99.352% |
| Caliway Biopharmaceuticals Co., Ltd. | -487.95 Million TWD | 99.421% |